1. Zhang, Peipei, Zhang, Weiguang, Wang, Xiaoqing, Kang, Mingqiang, Ding, Chen. 2024. BCLAF1 drives esophageal squamous cell carcinoma progression through regulation of YTHDF2-dependent SIX1 mRNA degradation. In Cancer letters, 591, 216874. doi:10.1016/j.canlet.2024.216874. https://pubmed.ncbi.nlm.nih.gov/38636894/
2. Sarras, Haya, Alizadeh Azami, Solmaz, McPherson, J Peter. 2010. In search of a function for BCLAF1. In TheScientificWorldJournal, 10, 1450-61. doi:10.1100/tsw.2010.132. https://pubmed.ncbi.nlm.nih.gov/20661537/
3. Shao, Anwen, Lang, Yue, Wang, Mengdong, Zhang, Shuo, Tang, Jun. 2020. Bclaf1 is a direct target of HIF-1 and critically regulates the stability of HIF-1α under hypoxia. In Oncogene, 39, 2807-2818. doi:10.1038/s41388-020-1185-8. https://pubmed.ncbi.nlm.nih.gov/32029898/
4. Shang, Yangyang, Jiang, Tao, Ran, Lijian, Chen, Lei, Wang, Rongquan. 2022. TET2-BCLAF1 transcription repression complex epigenetically regulates the expression of colorectal cancer gene Ascl2 via methylation of its promoter. In The Journal of biological chemistry, 298, 102095. doi:10.1016/j.jbc.2022.102095. https://pubmed.ncbi.nlm.nih.gov/35660018/
5. Zhang, Yang, Zhang, Xiaofang, Cai, Benzhi, Lu, Yanjie, Pan, Zhenwei. 2021. The long noncoding RNA lncCIRBIL disrupts the nuclear translocation of Bclaf1 alleviating cardiac ischemia-reperfusion injury. In Nature communications, 12, 522. doi:10.1038/s41467-020-20844-3. https://pubmed.ncbi.nlm.nih.gov/33483496/
6. Yan, Huan, Wu, Xiang, Li, Hong, Yu, Zongdong, Jin, Xiaofeng. 2024. Pan-Cancer Analysis Identifies BCLAF1 as a Potential Biomarker for Renal Cell Carcinoma. In Biochemical genetics, , . doi:10.1007/s10528-024-10773-x. https://pubmed.ncbi.nlm.nih.gov/38573525/
7. Dell'Aversana, C, Giorgio, C, D'Amato, L, Stunnenberg, H G, Altucci, L. 2017. miR-194-5p/BCLAF1 deregulation in AML tumorigenesis. In Leukemia, 31, 2315-2325. doi:10.1038/leu.2017.64. https://pubmed.ncbi.nlm.nih.gov/28216661/
8. Qin, Chao, Zhang, Rui, Lang, Yue, Yu, Cuilian, Tang, Jun. 2019. Bclaf1 critically regulates the type I interferon response and is degraded by alphaherpesvirus US3. In PLoS pathogens, 15, e1007559. doi:10.1371/journal.ppat.1007559. https://pubmed.ncbi.nlm.nih.gov/30682178/
9. Chen, Jiaxin, Wang, Huijuan, Xu, Jianbin, Ju, Zhenyu, Song, Zhangfa. 2024. CircZFR promotes colorectal cancer progression via stabilizing BCLAF1 and regulating the miR-3127-5p/RTKN2 axis. In Science China. Life sciences, 67, 1881-1898. doi:10.1007/s11427-023-2514-y. https://pubmed.ncbi.nlm.nih.gov/38805063/